Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

American Treatment Network Opens In Kent County; Awarded State Contract to Treat Uninsured Residents of Delaware


American Treatment Network Opens In Kent County Opioid Treatment Program

American Treatment Network Opens In Kent County

Our evidenced based model, is built around treatment for Opioid Use Disorder using the evidenced based gold standards of methadone, buprenorphine, or long acting injectables in combination with a full spectrum of medical and behavioral health interventions.

American Treatment Network announced the opening of its second innovative integrative treatment program for outpatient substance use disorder and mental health in the state of Delaware. The federally licensed Opioid Treatment Program “OTP” is located at 1206 Forrest Avenue, Dover, De. The location offers a full continuum of addiction treatment and mental health services in Kent County. We continue to face the worst of our nations Opioid Epidemic that show no signs of subsiding. Over 107,000 drug overdose deaths nationwide and 515 in the State of Delaware make resources such as American Treatment Network a valued resource in the state.

“Our evidenced based model, is built around treatment for Opioid Use Disorder using the evidenced based gold standards of methadone, buprenorphine, or long acting injectables in combination with a full spectrum of medical and behavioral health interventions” stated company co-founder and CEO Matthew Sullivan. He continued, “our care model has lowered the barriers to care by offering a complete ecosystem where our patients can access step down levels of care that offers primary care, medication assisted treatment, mental health medication management, intensive outpatient (IOP), and individual & group counseling in a welcoming holistic healing environment.”

Many patients struggle with co-occurring medical and psychological disorders in addition to their SUD. ATN’s ecosystem of care allows patient access to specialty providers board certified in addictionology, psychiatry, and primary care. These specialists are joined by a multi-disciplinary team of social workers, therapists, and care coordinators that come together to provide access to a full level of support during the recovery journey. This value-based approach has been proven to increase treatment sobriety and engagement, while lowering the total cost of care. “Our model is open access and we treat all who need our services in the state regardless of the ability to pay. We have a contract in Delaware for the uninsured of the state and removes financial concerns as an obstacle to care” states company COO Thomas Connor.

About American Treatment Network:

American Treatment Network is a value based, multi-state outpatient substance abuse provider with operations throughout Pennsylvania and Delaware. American Treatment Network, was founded to disrupt the current fragmented outpatient addiction treatment landscape by promoting health equity to all who seek outpatient addiction care. For more information, visit http://www.americantreatmentnetwork.com or call 877-286-5115

Share article on social media or email:

Trialbee and Acclinate to Host Informational Webinar on the 5 Key Trends Poised to Significantly Improve Clinical Trial Patient Diversity in 2023


News Image

Only together will we help people and their families become more ready to participate in clinical research, and that’s what I am so excited to discuss with everyone on the webinar.

Trialbee, the leader in data and technology-based patient recruitment and enrollment for clinical trials, and Acllinate, whose NOWINCLUDED™ community accesses and engages diverse populations on health-related issues, will together present an informational webinar entitled, “5 Key Trends: Are Your Clinical Trials Ready for Diversity in 2023?”

The webinar will be held live from Acclinate’s headquarters in Birmingham, Alabama, on January 25 (10am-11am ET) with Trialbee CEO Matt Walz alongside Acclinate Co-Founder and CEO Del Smith, PhD.

Register to attend the webinar.

Agenda topics include…


  • The business imperative of earlier and sustained patient engagement
  • Trust-enabling technologies for community collaboration
  • Leveraging real-world data (RWD) to target precise locations
  • Using a robust platform for recruitment tracking and results management
  • Adequate and equitable incentives, the changing regulatory landscape, and more

“Our mission at Acclinate is clear – to access and engage communities of color to create more inclusive research – but it cannot be our mission alone,” said Smith. “We need the entire clinical research industry, we need healthcare providers, and we need community and religious leaders to drive change through trust, open information sharing, and active listening. Only together will we help people and their families become more ready to participate in clinical research, and that’s what I am so excited to discuss with everyone on the webinar.”

“Industry conversations the past two years have significantly raised the stakes and the visibility for the lack of diversity in clinical trials, and I believe we are on the precipice of making real strides this year if focus on the communities we all serve,” said Walz. “I also believe it is time for technology that provides transparency into the recruitment and enrollment process across all sites, channels, methods, and partners – giving sponsors and CROs the data and tools they need to manage performance and accountability that leads to results.”

The webinar will be recorded and made available for on-demand viewing after the event for everyone who signs up.

About Acclinate Acclinate’s vision is health equity through inclusive research. We are a digital health company specializing in accessing and engaging communities of color so they can make informed decisions about clinical trial participation. Learn more at https://www.acclinate.com.

About Trialbee

Trialbee is the leading global data and technology platform for patient recruitment and enrollment in clinical trials. Trialbee Hive™ operationalizes real world data (RWD) and applies data science to find patients globally. Trialbee Honey™ simplifies the journey into clinical research for patients, reduces the burden of enrolling patients for sites and provides real-time, data-driven insights to sponsors and CROs so they can optimize enrollment timelines. Partnering with sponsors, CROs, and virtual/decentralized sites and software providers, Trialbee is achieving patient enrollment goals and driving enhancements in diversity in clinical trial populations. We are the smartest way to match and enroll patients for your clinical trial. For more information, visit http://www.trialbee.com or contact us at solutions@trialbee.com.

Share article on social media or email:

Enchanted Traditions, LLC, Modernizes Family Traditions; Creates the Tooth Fairy’s Tech-Enabled Little Helper


Dr. Joya Lyons, DDS, with The Tooth Fairy and The Enchanted Tooth Box children’s book and The Enchanted Tooth Box®. Photo: Ariel Perry Photography

“Enchanted Traditions helps mothers and families create magical memories with their little ones. Life moves so fast and moments we treasure most are fleeting. It’s important that the ability to maintain traditions be as technologically advanced as the times in which we live,” said Dr. Joya Lyons.

Enchanted Traditions, LLC, today launched “The Tooth Fairy and The Enchanted Tooth Box” children’s book and The Enchanted Tooth Box®, designed to help families capture memories and carry on family traditions across generations. Founded by wife, mother, and serial entrepreneur Dr. Joya Lyons, DDS, Enchanted Traditions, LLC, empowers parents to nurture family connections and create positive memories.

“As entrepreneurs juggling careers, chores, and growing to-do lists in addition to two children under 8 years old, my husband and I found it difficult to wake up in the middle of the night to play Tooth Fairy,” said Dr. Joya Lyons. “However, the desire to make this moment magical for our children outweighed our exhaustion. I wanted my kids to experience the same joy and wonder I did as a child, so I got to work.”

Merging her roles as mother and cosmetic dentist, Dr. Joya Lyons invented The Enchanted Tooth Box® and authored “The Tooth Fairy and The Enchanted Tooth Box” children’s book to give the Tooth Fairy the modern, tech-enabled boost needed to keep up with busy parents and distracted kids.

The Tooth Fairy and The Enchanted Tooth Box children’s book tells the story of how the Tooth Fairy completes her nightly mission even when faced with obstacles. The story opens with a girl named Brielle who loses her first tooth and eagerly anticipates a visit from the Tooth Fairy. Instead, she wakes up moneyless, disappointed, and wanting answers. Brielle then discovers a mysterious Enchanted Tooth Box and a note from the Tooth Fairy explaining her doozy of a mission, the need for the tooth box, and how the box’s fairy dust removes the challenges of retrieving teeth from under a child’s pillow; allowing the Tooth Fairy to complete her mission.

The Enchanted Tooth Box® is a mechanical keepsake box that exchanges parents’ (we mean the Tooth Fairy’s) gifts with a child’s tooth while everyone in the household sleeps. No more stressing over getting up in the middle of the night to complete the delicate-yet-nerve-wrecking job of swapping teeth for gifts under a sleeping child’s pillow. This convenient device does all the hard work for parents. The Tooth Fairy receives all of the praise, parents receive all of the satisfaction, and children receive all of the joy.

From parents to grandparents to aunts and uncles, everyone can play a role in adding a bit of magic to children’s lives. Products are available for sale beginning February 24, 2023: The Tooth Fairy and The Enchanted Tooth Box children’s book for $27.99; The Enchanted Tooth Box® for $59.99; and The Enchanted Bundle for $79.99. For purchases and details, visit http://www.enchantedtraditions.com.

# # #

About Enchanted Traditions, LLC

Founded by Dr. Joya Lyons in 2022, Enchanted Traditions, LLC is a Charlotte, North Carolina-based, Black-woman-owned company that makes children’s picture storybooks, toys, and merchandise, all based on keeping family traditions alive. What started out as a mom excitedly wanting her daughter to experience the tradition of The Tooth Fairy like she did as a child turned into something much more magical. Our goal is to aid in the development of children through vivid imagination and nurture the family connection through family tradition, thus creating positive memories for children and a stronger family bond. For more, visit http://www.enchantedtraditions.com and follow us @enchantedtraditions on Instagram.

Share article on social media or email:



Los Angeles Vasectomy and Vasectomy Reversal Specialist Dr. Justin…


Find Local Doctors has selected prominent urologist Dr. Houman for this award due to his large volume of five-star reviews from patients across multiple online sources.

(PRWeb January 19, 2023)

Read the full story at https://www.prweb.com/releases/los_angeles_vasectomy_and_vasectomy_reversal_specialist_dr_justin_houman_is_recognized_as_a_2023_top_patient_rated_los_angeles_urologist_by_find_local_doctors/prweb19113368.htm

The Consulting Report’s Top 25 Operations Consultants and Leaders of 2023


The Consulting Report is pleased to announce The Top 25 Operations Consultants and Leaders of 2023. The global economy has faced no shortage of interconnected challenges in the past several years, from a seemingly never-ending pandemic, to armed conflicts, to ongoing supply chain woes. The 25 exceptional people on this year’s list have earned their places thanks to their commitment to optimizing their clients’ value chains, countering the many challenges facing businesses with innovation and unparalleled expertise across a range of practice areas. Often, they are not just mitigating the effects of difficult situations, but enacting transformational change within businesses.

Some of the distinguished leaders on this year’s list include Jim Kilpatrick, Partner and Global Supply Chain & Network Operations Leader for Deloitte, who has led his firm’s perspectives, initiatives, and investments to help keep critical global supply chains flowing during disruption and volatility. Meanwhile, in 2022, PwC UK’s Lead Partner of Supply Chain and Operations, Alistair Kett, led the acquisition of Olivehorse, a leading consultancy specializing in supply chain management, which strengthened PwC’s FT Gold Medal ranked supply chain capability. And Gautam Narayan, Director in Slalom’s Global Supply Chain practice, has helped grow Slalom’s fledgling supply chain capabilities into a multimillion-dollar business.

The awardees on this year’s list lead from a host of positions, from Managing Director to Partner, Executive Vice President, and Principal, among others. What they share is their dedication to optimizing business operations for their clients, setting them up for growth now and into the future. Please join us in celebrating The Top 25 Operations Consultants and Leaders of 2023.

Jim Kilpatrick (Deloitte), Dharmendra Patwardhan (Capgemini), Fredrik de Maré (FTI Consulting), Glenn Steinberg (EY), Alistair Kett (PwC UK), Takshay Aggarwal (IBM), Gautam Narayan (Slalom), James Hannah (General Dynamics Information Technology), Jose Bleda (Accenture), Andrew Underwood (KPMG), Chris Monk (Protiviti), Jeree Hanavec (World Wide Technology), Bernd Schreiber (Arthur D. Little), Daniel Swan (McKinsey & Company), Allison Kahler (Bain & Company), Jeffery Gallart (Teneo), Michael Lierow (Oliver Wyman), Ben YoKell (Grant Thornton), Andrew Owen (Alvarez & Marsal), Jeffrey Groux (Raytheon Technologies), Geoff Ibbotson (Atos), Ankit Tiwari (Tata Consultancy Services), Corey Biven (SAIC), Claire Brockbank (QinetiQ), Casey Chapman (RSM US).

The full article can be read at https://thehealthcaretechnologyreport.com/

About The Healthcare Technology Report

The Healthcare Technology Report provides market research and insights, business news, investment activity updates, and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers, and media professionals highly knowledgeable on healthcare technology and the various companies, executives, and investors that make up the sector.

Share article on social media or email:

ISET celebrates 35th anniversary meeting with nearly 1,000 registrants, record-breaking number of research submissions, sold out Exhibit Hall


ISET logo

HMP Global’s International Symposium on Endovascular Therapy is the premier arena for pioneering and practical endovascular education.

For its 35th annual gathering, HMP Global’s International Symposium on Endovascular Therapy (ISET) received a record-breaking amount of research submissions, welcomed nearly 1,000 registrants from around the globe, and hosted more than 40 companies in its sold-out Exhibit Hall, solidifying its position as the premier arena for pioneering and practical endovascular education.

ISET 2023 was held January 16-19 in Miami Beach, Fla., and welcomed the current and future legends in the field to explore groundbreaking techniques, technologies, and procedures while exchanging discussion and debate that ultimately drives patient care forward.

ISET’s founder and course director is Barry T. Katzen, MD, FACC, FACR, FSIR, founder and Chief Medical Executive of the Miami Cardiac & Vascular Institute; Chief Medical Innovation Officer, Baptist Health South Florida; and professor and founding chairman of the Department of Radiology at Florida International University, Herbert Wertheim College of Medicine in Miami.

“From the group that pioneered live case education, ISET has grown tremendously since the first meeting 35 years ago,” Katzen said. “Now as the leading meeting in endovascular therapy, ISET brings together a multidisciplinary faculty and audience to discuss groundbreaking techniques, implement change, and improve patient care. As the field continues to evolve, so will ISET. We are encouraged by the passion and energy exuded at this year’s conference and will continue to provide innovative education in the years to come.”

This year, 153 research abstracts were submitted for presentation, shattering previous records. All abstracts underwent blind peer review for quality of research, educational or scientific content, logical presentation, and impact on healthcare. Cutting-edge research e-posters were displayed on multimedia screens in the poster area of the Exhibit Hall at ISET, and late-breaking data was presented at the first major endovascular meeting in 2023.

This year’s award winners include:


  • Young Investigator Award (abstract award)


Title: “Effects of Changes in Volume Status in Patients with May-Thurners”

Author: Lauren Conway, MD, venous vascular surgery fellow, University of Maryland Medical Center

  • Best Poster Award (abstract award)


Title: “Time to Mechanical Thrombectomy Does Not Impact In-Hospital Outcomes for Acute Submassive Pulmonary Embolism”

Authors: Zain M. Khazi, MD, resident physician, University of Missouri-Columbia; and Ambarish Bhat, MD, assistant professor of radiology, University of Missouri-Columbia

  • Charles Tegtmeyer Annual Lecture: Past, Present and Future of Carotid Stenting


Presented by William A. Gray, MD, FACC, FSCAI, System Chief, Division of Cardiovascular Diseases of Main Line Health; and President, Lankenau Heart Institute


John Kaufman, MD, MS, FSIR, Chair, Department of Interventional Radiology of Dotter Interventional/OHSU

ISET 2023 was strengthened through continued endorsement from the Society of Interventional Radiology (SIR), continued partnership with the Society for Vascular Medicine (SVM), and a recently added educational partnership with the Society for Vascular Surgery (SVS), which collaborated on overall programming and provided two new vascular surgery Course Directors to this year’s expert lineup. With the support of these partnerships, ISET featured a bold scientific program covering the complete landscape of endovascular therapy practice and challenges.

Participants joined ISET 2023 from more than 20 countries around the globe for an educational program presented by more than 85 of the world’s foremost faculty presenters. Programming included focused symposia, “Essentials of Endovascular Therapy” co-developed by SVM, and “Non-Invasive Vascular Diagnosis,” during the pre-symposium day, and an informative Town Hall on “The Movement of Endovascular Procedures to the Ambulatory Space,” supported by an educational grant from Philips.

Live cases were presented by Miami Cardiac & Vascular Institute, University Hospital Leipzig, University of Pennsylvania, and Advanced Cardiac & Vascular Centers for Amputation Prevention. The educational agenda also featured dedicated sessions on PAD, embolotherapy, CLI, venous, PE, clot management, and an aortic update.

More than 40 supporting companies filled the ISET’s sold-out Exhibit Hall, offering attendees opportunities to learn about a wide range of services and equipment to best serve their needs and improve patient care.

ISET offered the opportunity to earn more than 40 CME/CNE credits through its Maximum Value Package. Clinicians who were not able to join in person may register for the MVP package and receive accredited session recordings on-demand, accessible in early February and available for 90 days.

For more information, visit iset.org.

ABOUT HMP GLOBAL 

HMP Global is the force behind Healthcare Made Practical — and is an omnichannel leader in healthcare content, events, and education, with a mission to improve patient care. The company produces accredited medical education events — in person and online via its proprietary VRTX virtual platform — and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include the HMP Global Learning Network, healthcare’s most comprehensive source for news and information; Psych Congress, the largest independent mental health meeting in the U.S.; the Evolution of Psychotherapy, the world’s largest independent educational event for mental health professionals; the Leipzig Interventional Course (LINC), the leading, global gathering for interdisciplinary cardiovascular specialists; EMS World Expo, North America’s largest EMT and paramedic event; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. For more information, visit hmpglobal.com

ISPE Announces Leaders from the White House, FDA, Merck, Catalent, & More at Facilities of the Future Conference


The International Society for Pharmaceutical Engineering (ISPE) announced keynote speakers for the 2023 ISPE Facilities of the Future Conference, taking place 31 January–1 February 2023 in North Bethesda, Maryland, USA, and virtually. This signature event brings together top pharmaceutical industry and regulatory leaders who will provide an actionable understanding of transformational technologies and their application across the breadth of biologics and pharmaceutical manufacturing facilities.

The 2023 ISPE Facilities of the Future Conference features a dynamic line-up of thought-provoking keynote presentations led by some of the most prominent names in the pharmaceutical industry.

Confirmed Keynote Speakers:

  • Matthew Hepburn, M.D., Senior Advisor to the OSTP Director on Pandemic Prevention, U.S. Office of Science and Technology Policy, Executive Office of the President
  • Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research, CBER/FDA
  • Arlene Joyner, MS PMP, CSSGB, Branch Chief, CDMO Network, PCI/BARDA/ASPR/HHS
  • Thomas Warf, Expert Consultant, DHHS/OS/ASPR/BARDA
  • Jeffrey Baker, PhD, Retired, Former Regulator, FDA/CDER
  • Kerren Bergman, CEO, Hyde Engineering + Consulting Inc
  • Jim Collins, President, Pharmaceutical Delivery Systems LLC
  • Patricia Hurter, PhD, CEO, Lyndra Therapeutics
  • Martin Johnson, PhD, Vice President, Engineering, Synthetic Molecule Design and Development, Eli Lilly
  • John Machulski, VP, Engineering, Biologics & CGT, Catalent
  • James Stephanou, VP, Global Engineering Solutions, Merck

To learn more about this event and to register, visit ISPE.org/FOF23.

About ISPE

The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest nonprofit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 20,000+ members of ISPE provide solutions to complex pharmaceutical industry challenges through innovation, member and workforce development, and technical, regulatory, and compliance collaborations in more than 120 countries worldwide. Founded in 1980, ISPE has its worldwide headquarters and training center in North Bethesda, Maryland, USA, and its operations center in Tampa, Florida, USA. For more information, visit ISPE.org.

Share article on social media or email:

$1.3 Billion Liquid Biopsy Market the Present and Future of Clinical Oncology


“Industry growth through 2027 will be driven by a shift toward personalized medicine, and growing acceptance of liquid biopsy technologies by the medical community.” – Kalorama Information

The global market for liquid biopsy diagnostic tests reached an estimated $1,267 million ($1.3 billion) in 2022, led by demand for diagnostics in guiding therapeutic decisions. The market is forecast to almost triple over the next several years, approaching $3.9 billion in 2027, according to medical market research firm Kalorama Information in the new report The World Market for Liquid Biopsy, 2023.

Liquid biopsies are a set of minimally invasive diagnostic methods that analyze tumor-derived materials that can be found circulating in biological fluids, to provide information for the diagnosis, treatment, and monitoring of cancer. The liquid biopsy market can be segmented by the type of analyte detected and analyzed. There are four main categories: circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), exosomes and other analytes, and multiple analytes. ctDNA-based tests represent the bulk of the market.

The market for liquid biopsy testing is in its early stages. As with many new technologies, the adoption rate of liquid biopsy testing is following a curve pattern, where early adoption will occur at a slower rate, but quickly pick up pace. The liquid biopsy market has reached the point that the pace of adoption is gaining momentum, and will rapidly increase over the forecast period through 2027.

Growth of the overall market revenues is expected to be propelled by several factors, including: the introduction of new products for various clinical applications, in particular therapy guidance and early diagnosis; the rising incidence and prevalence of cancer in most major markets; and growing awareness among clinicians and patients about less-invasive diagnostic and monitoring technologies.

“Obviously, tissue biopsies and imaging techniques remain the current standards of care in the diagnosis of solid tumors. However, they have risks and limitations, some of which can be overcome by the use of liquid biopsy in clinical oncology, as an alternative or complementary technique to the current standards of care,” says Bruce Carlson, publisher of Kalorama Information, a subsidiary of Science and Medicine Group.

Liquid biopsy testing has many potential applications in aspects of clinical oncology, including:

  • as an early detection and diagnosis/screening
  • as an alternative testing method when tissue biopsy is difficult/impossible, or when the primary site of metastatic disease is unknown
  • for therapy personalization and monitoring – by molecular characterization of a patient’s disease, clinicians can select the optimal course of therapy and monitor efficacy over time, as well as quickly react to adjust therapy should treatment resistance arise
  • for disease monitoring – to observe disease progression, tumor evolution, residual disease, and early detection of recurrence
  • for prognosis of disease

North America, particularly the United States, is the greatest source of demand for liquid biopsy testing, followed by Europe. Liquid biopsy-based testing is gaining acceptance by third-party payors in the US, making testing more accessible to patients. The majority of companies in the market are based in the US. Many focus their attention and marketing efforts exclusively on the US market. Meanwhile, in Europe, a significant proportion of liquid biopsy tests have been granted CE-IVD marking, granting them market access throughout the European Union, as well as other countries that recognize the CE-mark, in Europe and beyond.

Despite trailing North America and Europe, the Asia Pacific region is ripe with intrigue and opportunity. In the Asia Pacific region, the incidence of cancer is rising, but so is healthcare spending. Accordingly, companies in the liquid biopsy space are beginning to increase their presence in the Asia Pacific market. Slowly, new companies are emerging in the region, while more established companies are expanding their presence through regional offices or strategic partnerships.

PURCHASING THE REPORT

Dramatic changes have occurred in the liquid biopsy market, necessitating a resource to provide perspective on the market opportunity. This new report from Kalorama assesses the liquid biopsy market now and in 2027. The report can be useful for business planning, market share assessment, competitive research, and due diligence for mergers and acquisitions and other partnerships.

For more information or to purchase the market research report “The World Market for Liquid Biopsy, 2023,” visit: https://kaloramainformation.com/product/the-world-liquid-biopsy-market-2023/.

ABOUT KALORAMA INFORMATION

Kalorama Information, part of Science and Medicine Group, is the leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, medical devices, and pharmaceuticals. Science and Medicine Group supports companies seeking to commercialize the rapidly changing marketplace at the intersection of science, medicine, and technology. Comprised of industry-leading brands, Science and Medicine Group serves analytical instrument, life science, imaging, and clinical diagnostic companies by helping them create strategies and products to win markets and provide platforms to digitally engage their markets through a variety of innovative solutions. Kalorama Information produces 30 reports a year. The firm offers a Knowledge Center, which provides access to all published reports.

Share article on social media or email: